{
 "as_of": "2026-11-06",
 "cmr": "kr-cm-kg/KOSPI/950210",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Prestige BioPharma Limited (KOSPI: 950210) — research page\n\nAs of 2026-11-06 · kr-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Prestige BioPharma Limited, listed on KOSPI under ticker 950210, with ISIN KR8702070002. The LEI is not on the record. Its security type is Corporate and its sector is 자연과학 및 공학 연구개발업. Its segment and jurisdiction are not on the record. Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 42 filings across 21 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8.0 days. The record holds 66 days from the latest filing to the record date of 2026-11-06. The latest filing is dated 2026-09-01 and is of type corporate_news. The KOSPI median cadence gap is 7.0 days across 832 issuers, and the KOSPI median latency is 7.0 days. The sector median cadence gap is 7 days across 80 issuers, and the sector median latency is 15 days.\n\n## Auditor\n\nThe auditor of record is 삼덕회계법인, and its location is not on the record. The record does not carry auditor changes for this issuer.\n\n## Events and halts\n\nThe record does not carry listing, delisting, name change, domicile change or segment move lines for this issuer, because no lifecycle type map exists for this register. The issuer is listed and not halted.\n\n## Orderability\n\nThe outcome is not determinable, because the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe field has not been read.\n\n## Open research\n\nThe field has not been read.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage is not sealed for this market. No issuer years are sealed as served. The live record began on 2026-09-12. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13 (identity.exchange)\n- https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd (identity.isin)\n- https://opendart.fss.or.kr/api/company.json?corp_code=01510489 (identity.name)\n- https://mcp.kr-cm-kg.ai/events/KOSPI/950210 (the disclosure lines)\n- https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain (the halt flag)\n- https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250919000620 (the auditor)\n- https://mcp.kr-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.kr-cm-kg.ai/record/KOSPI/950210 (the record)\n",
 "market": "KR",
 "node": "kr-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-12",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the KR store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "read by Gemini (ko) — DART 사업보고서 text windows",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250919000620",
    "state": "filled",
    "value": "삼덕회계법인"
   },
   "auditor_firm_id": {
    "market": "KR",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "KR",
    "state": "not_on_record"
   },
   "changes": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "kr-cm-kg/KOSPI/950210",
  "coverage": {
   "note": "the coverage field has not been read for this issuer",
   "state": "not_read"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 832,
     "median_cadence_gap_days": 7,
     "median_filings": 49,
     "median_latency_days": 7,
     "name": "KOSPI"
    },
    "sector": {
     "issuers": 80,
     "median_cadence_gap_days": 7,
     "median_filings": 42.5,
     "median_latency_days": 15,
     "name": "자연과학 및 공학 연구개발업"
    }
   },
   "by_type": {
    "agm_egm": 3,
    "corporate_news": 14,
    "directors_dealings": 10,
    "exchange_bulletin": 1,
    "major_holder": 9,
    "regulatory_filing": 1,
    "results": 4
   },
   "cadence_median_gap_days": 8,
   "filing_days": 21,
   "filings": 42,
   "latency_days": 66,
   "latest": [
    {
     "category": null,
     "date": "2026-09-01",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260901800109",
     "title": "최대주주등소유주식변동신고서",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-09-01",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260901000026",
     "title": "임원ㆍ주요주주특정증권등소유상황보고서",
     "type": "directors_dealings"
    },
    {
     "category": null,
     "date": "2026-09-01",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260901000023",
     "title": "주식등의대량보유상황보고서(일반)",
     "type": "major_holder"
    },
    {
     "category": null,
     "date": "2026-08-25",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260825800279",
     "title": "[기재정정]단일판매ㆍ공급계약체결",
     "type": "corporate_news"
    },
    {
     "category": null,
     "date": "2026-08-19",
     "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260819800177",
     "title": "최대주주등소유주식변동신고서",
     "type": "corporate_news"
    }
   ],
   "latest_filing_date": "2026-09-01",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.kr-cm-kg.ai/events/KOSPI/950210",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "KOSPI"
   },
   "isin": {
    "read_by": "KRX stock finder (data.krx.co.kr finder_stkisu: full_code = the KRX standard code)",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd  [POST bld=dbms/comm/finder/finder_stkisu, mktsel=ALL]",
    "state": "sourced",
    "value": "KR8702070002"
   },
   "jurisdiction": {
    "market": "KR",
    "reason": "no DART corporate registration number and no LEI record",
    "state": "not_on_record"
   },
   "lei": {
    "market": "KR",
    "reason": "no GLEIF record with the exact English or Korean name",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "DART company.json (company profile per corp_code, keyed API)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://opendart.fss.or.kr/api/company.json?corp_code=01510489",
    "state": "sourced",
    "value": "Prestige BioPharma Limited"
   },
   "sector": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download) (업종)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "자연과학 및 공학 연구개발업"
   },
   "security_type": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "KR",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "950210"
   },
   "website": {
    "read_by": "KIND (KRX) listed-company list (corpList.do download)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13",
    "state": "sourced",
    "value": "http://www.prestigebiopharma.com"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "KR",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "KR",
  "node": "kr-cm-kg",
  "numbers_hash": "sha256:c0c0b08a4fe9c1ef9629282ecb5d7f061559fc4e09cf0c3106875b1b4abdd62a",
  "open_research": {
   "rows": [],
   "state": "not_read"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.kr-cm-kg.ai/book/aio.json",
    "door": "https://mcp.kr-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1",
   "section": "kr.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.kr-cm-kg.ai/record/KOSPI/950210",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:c0c0b08a4fe9c1ef9629282ecb5d7f061559fc4e09cf0c3106875b1b4abdd62a",
 "path": "/kr/KOSPI/950210",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Prestige BioPharma Limited, listed on KOSPI under ticker 950210, with ISIN KR8702070002. The LEI is not on the record. Its security type is Corporate and its sector is 자연과학 및 공학 연구개발업. Its segment and jurisdiction are not on the record. Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 42 filings across 21 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 8.0 days. The record holds 66 days from the latest filing to the record date of 2026-11-06. The latest filing is dated 2026-09-01 and is of type corporate_news. The KOSPI median cadence gap is 7.0 days across 832 issuers, and the KOSPI median latency is 7.0 days. The sector median cadence gap is 7 days across 80 issuers, and the sector median latency is 15 days.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is 삼덕회계법인, and its location is not on the record. The record does not carry auditor changes for this issuer.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record does not carry listing, delisting, name change, domicile change or segment move lines for this issuer, because no lifecycle type map exists for this register. The issuer is listed and not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable, because the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/kr/suitability-and-appropriateness-fscma-articles-46-and-46-2/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The field has not been read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The field has not been read.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage is not sealed for this market. No issuer years are sealed as served. The live record began on 2026-09-12. Years 2021, 2022, 2023, 2024, 2025 and 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://kind.krx.co.kr/corpgeneral/corpList.do?method=download&searchType=13"
  },
  {
   "for": "identity.isin",
   "source": "https://data.krx.co.kr/comm/bldAttendant/getJsonData.cmd"
  },
  {
   "for": "identity.name",
   "source": "https://opendart.fss.or.kr/api/company.json?corp_code=01510489"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.kr-cm-kg.ai/events/KOSPI/950210"
  },
  {
   "for": "the halt flag",
   "source": "https://kind.krx.co.kr/investwarn/tradinghaltissue.do?method=searchTradingHaltIssueMain"
  },
  {
   "for": "the auditor",
   "source": "https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20250919000620"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.kr-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.kr-cm-kg.ai/record/KOSPI/950210"
  }
 ],
 "title": "Prestige BioPharma Limited (950210) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}